机构:[1]West China School of Medicine, Sichuan University, Chengdu, China四川大学华西医院[2]Department of Thoracic Oncology, Cancer Center, West China Hospital, Medical School, Sichuan University, Chengdu, China四川大学华西医院[3]State Key Laboratory of Biotherapy, West China Hospital, Medical School, Sichuan University, Chengdu, China四川大学华西医院[4]Department of Pathology, West China Hospital, Medical School, Sichuan University, Chengdu, China四川大学华西医院[5]Department of Radiotherapy, Sichuan Province Cancer Hospital, Chengdu, China四川省肿瘤医院[6]Department of Oncology, Sichuan Academy of Medical Sciences and Sichuan Provincial People’s Hospital, Chengdu, China四川省人民医院[7]Department of Thoracic Surgery, West China Hospital, Medical School, Sichuan University, Chengdu, China四川大学华西医院
Primary sarcomas of the mediastinum are relatively rare. This article reviews the surgical outcomes of 21 cases diagnosed with localized mediastinal sarcomas receiving multidisciplinary treatment modalities in Sichuan province, China, from January 1996 to January 2011. Twenty-one cases of histologically diagnosed primary mediastinal sarcoma undergoing surgical treatment were reviewed retrospectively. Disease-free survival (DFS) and overall survival (OS) were statistically analysed. All the patients presented with localized tumours consisting of 5 females and 16 males with a median age of 41.0 years (range: 9.0-68.0 years). Among all cases, 17 (81.0%) had an Eastern Cooperative Oncology Group performance status score of < 1 at diagnosis. Eight (38.1%) underwent macroscopically complete resection (R0-R1) and 13 (61.9%) had incomplete resection (R2). Ten (47.6%) received postoperative radiotherapy and 7 (33.3%) postoperative chemotherapy. The median DFS was 17 months (range: 0.4-79.8 months) and the median OS was 27.2 months (range: 0.4-79.8 months). Patients receiving complete resection showed significantly improved DFS (P = 0.031) and OS (P = 0.035) compared with those with incomplete resection. Neither postoperative radiotherapy nor chemotherapy significantly improved DFS (P = 0.770, P = 0.756) or OS (P = 0.905, P = 0.738). However, 7 patients (R2) and 2 (R0-R1 and grade 3) had improved local control with a local recurrence-free survival of 28.9 months (range: 7.6-73.2 months). Complete resection should be preferentially attempted compared with incomplete resection and postoperative radiotherapy might yield good local control.
语种:
外文
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2013]版:
大类|4 区医学
小类|4 区心脏和心血管系统
最新[2023]版:
大类|4 区医学
小类|4 区心脏和心血管系统4 区呼吸系统4 区外科
JCR分区:
出版当年[2013]版:
Q4CARDIAC & CARDIOVASCULAR SYSTEMS
最新[2023]版:
Q2SURGERYQ3CARDIAC & CARDIOVASCULAR SYSTEMSQ3RESPIRATORY SYSTEM
第一作者机构:[1]West China School of Medicine, Sichuan University, Chengdu, China
通讯作者:
通讯机构:[2]Department of Thoracic Oncology, Cancer Center, West China Hospital, Medical School, Sichuan University, Chengdu, China[3]State Key Laboratory of Biotherapy, West China Hospital, Medical School, Sichuan University, Chengdu, China[*1]Department of Thoracic Oncology, Cancer Center, West China Hospital, Medical School, Sichuan University, No. 37 Guo Xue Xiang, Chengdu, Sichuan 610041, China
推荐引用方式(GB/T 7714):
Luo Da-Xian,Huang Mei-Juan,Xiong Bo,et al.Primary mediastinal sarcoma: surgical outcomes of 21 cases[J].INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY.2013,17(6):982-986.doi:10.1093/icvts/ivt354.
APA:
Luo, Da-Xian,Huang, Mei-Juan,Xiong, Bo,Li, Tao,Xie, Ke...&Lu, You.(2013).Primary mediastinal sarcoma: surgical outcomes of 21 cases.INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY,17,(6)
MLA:
Luo, Da-Xian,et al."Primary mediastinal sarcoma: surgical outcomes of 21 cases".INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY 17..6(2013):982-986